Cytokine levels in serum of patients with juvenile rheumatoid arthritis

• Published in: Clinical rheumatology 2001, Vol.20 (1), p.30-35
• Main Authors: Yilmaz, M, Kendirli, S G, Altintas, D, Bingöl, G, Antmen, B
• Format: Article
• Language: English
• Subjects: Adolescent; Arthritis, Juvenile - blood; Arthritis, Juvenile - pathology; Child; Child, Preschool; Cytokines - blood; Drug therapy; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Interleukin-1 - blood; Interleukin-12 - blood; Interleukin-6 - blood; Interleukin-8 - blood; Male; Statistics as Topic; Statistics, Nonparametric; Tumor Necrosis Factor-alpha - analysis
• ISSN: 0770-3198; 1434-9949
• DOI: 10.1007/s100670170100

We investigated serum levels of interleukin (IL)-1beta, IL-6, IL-8, IL-12 and tumour necrosis factor (TNF)-alpha in JRA patients during both active and inactive phases of the disease. The systemic JRA patients had the highest IL-1beta and IL-6 levels during both active and inactive periods. In the systemic group IL-1beta, IL-6 and IL-12 levels during the active period were elevated compared to the inactive period (p = 0.0173, p = 0.0359 and p = 0.0117, respectively). Levels of these cytokines during the inactive stage were still greater than those of controls. IL-8 and TNF-alpha levels during both active and inactive periods were comparable to controls. IL-1beta correlated strongly with CRP and ESR (p = 0.008 and p = 0.031, respectively). IL-6 correlated significantly with CRP (p = 0.002). IL-12 levels were found to be correlated with ESR and CRP (p = 0.03 and p = 0.04, respectively). In active polyarticular JRA patients, IL-6 levels were elevated compared to the inactive phase, and the control (p = 0.001) IL-12 levels decreased significantly with clinical remission (p = 0.018). There was a strong correlation between 11-12 levels and number of joint with limited motion (p = 0). In oligoarticular JRA patients, IL-12 levels during active period were greater than in the controls and there was a marked decrease in IL-12 levels when the patients entered the inactive phase (p = 0.001) In conclusion, IL-1beta, IL-6 and IL-12 may play an important role in JRA and may be used as a marker of disease activity.